A new study reports a genetically modified poliovirus therapy has been shown to improve long term survival rates in recurrent glioblastoma brain cancer patients. Researchers say the therapy had a three year survival rate for 21 percent of participants in a phase 1 clinical trial, compared to just 4% of patients who received more standard treatments.
Artificial IntelligenceBrain CancerDeep LearningFeaturedNeurologyNeuroscienceOpen Neuroscience Articles··5 min read
Georgia Tech researchers are calling on machine learning specialists and cancer researchers to help discover potential new therapies for oncological diseases.
Researchers report a targeted therapy that blocks LSD1 effectively shrinks tumor size in mouse models of medulloblastoma, a form of pediatric brain cancer.
A new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers.
Researchers find possible markers for brain cancers in the neural crest.
Researchers have identified an abnormal metabolic pathway which drives cancer cell growth in particular glioblastoma brain cancer subtypes.
A compound used to treat leukemia shows promise in preventing breast cancer cells from metastasizing in the brain.
Targeting the gene WWP1 with indole-3-carbinol, a compound found in broccoli and other cruciferous vegetables, suppressed tumor growth in animal models of cancer.
According to a Cell Reports study, mice with abnormal eating schedules are more likely to develop skin cancer cells. Researchers report abnormal eating times disrupt the skin's circadian cycle and weakens the potency of an enzyme that protects against UV rays.
Researchers have identified a mechanism that integrates signals from the ongoing repair process and the cell death machinery.